Discrepant Thyroid Function Tests in a Patient Treated with Interferon-Alpha

Carella C. , Mazziotti G. , Morisco F. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab 2001; 86: 1925–9

Sacchi S. , Kantarjian H. , O'Brien S. , Cohen P.R. , Pierce S. , Talpaz M. Immune-mediated and unusual complications during interferon alpha therapy in chronic myelogenous leukaemia. J Clin Oncol 1995; 13: 2401–7

Sapin R. , Gasser F. , Schlienger J.L. Familial dysalbuminemic hyperthyroxinemia and thyroid hormone autoantibodies: interference in current free thyroid hormone assays. Horm Res 1996; 45: 139–41

Wesche B. , Jaeckel E. , Trautwein C. Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C. Gut 2001; 48: 378–83

Gisslinger H. , Gilly B. , Woloszczuk W. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol 1992; 90: 363–7

Sakata S. , Matsuda M. , Ogawa T. Prevalence of thyroid hormone autoantibodies in healthy subjects. Clin Endocrinol (Oxf) 1994; 41: 365–70